Population Sciences, Translational Research, and the Opportunities and Challenges for Genomics to Reduce the Burden of Cancer in the 21st Century

Population Sciences, Translational Research, and the Opportunities and Challenges for Genomics to Reduce the Burden of Cancer in the 21st Century

1. Muin J. Khoury1,2, 
2. Steven B. Clauser2, 
3. Andrew N. Freedman2,
4. Elizabeth M. Gillanders2, 
5. Russ E. Glasgow2, 
6. William M.P. Klein2, and
7. Sheri D. Schully2

+Author Affiliations

1. Authors' Affiliations: ¹Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia and ²Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland

1. Corresponding Author:
   Muin J. Khoury, CDC, 1600 Clifton Road, Atlanta, Georgia 30333. Phone: 40-449-8001; Fax: 404-498-0140; E-mail: muk1@CDC.GOV

 

Next Section

Abstract

Advances in genomics and related fields are promising tools for risk assessment, early detection, and targeted therapies across the entire cancer care continuum. In this commentary, we submit that this promise cannot be fulfilled without an enhanced translational genomics research agenda firmly rooted in the population sciences. Population sciences include multiple disciplines that are needed throughout the translational research continuum. For example, epidemiologic studies are needed not only to accelerate genomic discoveries and new biological insights into cancer etiology and pathogenesis, but to characterize and critically evaluate these discoveries in well-defined populations for their potential for cancer prediction, prevention and response to treatment. Behavioral, social, and communication sciences are needed to explore genomic-modulated responses to old and new behavioral interventions, adherence to therapies, decision making across the continuum, and effective use in health care. Implementation science, health services, outcomes research, comparative effectiveness research, and regulatory science are needed for moving validated genomic applications into practice and for measuring their effectiveness, cost-effectiveness, and unintended consequences. Knowledge synthesis, evidence reviews, and economic modeling of the effects of promising genomic applications will facilitate policy decisions and evidence-based recommendations. Several independent and multidisciplinary panels have recently made specific recommendations for enhanced research and policy infrastructure to inform clinical and population research for moving genomic innovations into the cancer care continuum. An enhanced translational genomics and population sciences agenda is urgently needed to fulfill the promise of genomics in reducing the burden of cancer.Cancer Epidemiol Biomarkers Prev; 20(10); 2105–14. ©2011 AACR.

Previous SectionNext Section

The Widening Gap between Basic Genomic Discoveries and Their Impact on the Population Burden of Cancer

Development of Personalized Medicine: A Population Perspective

Medicine gets up close and personal. Long-term study will monitor healthy people in detail — and encourage them to respond to the results. 
W. Wayt Gibbs Nature 11 February 2014

100 people commit their bodies to science in new study, Ken Sheridan, Yahoo News, Feb 14

Project to collect 100,000 people's medical data. Tracking microbiomes, blood tests and more over decades could provide individual health recommendations, by Tina Hesman Saey, Science News, Feb 15

Participatory medicine: a driving force for revolutionizing healthcare.
Hood L, Auffray C. Genome Med. 2013 Dec 23;5(12):110.

Systems biology and P4 medicine: past, present, and future.
Hood L. Rambam Maimonides Med J. 2013 Apr 30;4(2):e0012.

CDC paper: A population perspective on personalized medicine

CDC paper:  Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.